Serum ischemia-modified albumin level returns to its premenopausal level with 1-year hormone therapy in healthy menopausal women

Creative Commons License

Cetin E. C., GÜVEN S., Sal H., Guven E. S., MENTEŞE A.

MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, cilt.20, sa.2, ss.76-80, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5114/pm.2021.106089
  • Dergi Adı: MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.76-80
  • Anahtar Kelimeler: IMA, menopause, hormone therapy, cardiovascular risk, ESTROGEN PLUS PROGESTIN, POSTMENOPAUSAL WOMEN, ENDOTHELIAL FUNCTION, REPLACEMENT THERAPY, PREVENTION, ESTRADIOL, RISK
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Introduction: To assess the effect of hormone therapy (HT) on serum ischemia modified albumin (IMA) levels in healthy menopausal women.